Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000452 · ClinicalTrials.gov registry record · Phase 4
Naltrexone Treatment of Alcohol Dependence
A Phase 4 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
NCT00000452 is a Phase 4 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 240 participants.
The verdict
NCT00000452, a Phase 4 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
Study Summary
The long-range goal of this ongoing research program is to find more effective treatments for alcohol dependence by combining medication with the appropriate psychosocial support. This proposal has three specific aims: (1) to compare the effectiveness of naltrexone (Revia) in three types of treatment settings; (2) to assess the effects of psychosocial support on medication compliance and treatment retention; and (3) to investigate the individual characteristics that may predict who is likely to benefit from additional psychosocial support versus simple medication management.
Interventions
- BEHAVIORAL Cognitive Behavior Therapy
- DRUG naltrexone (Revia)
- BEHAVIORAL Compliance Enhancement Tech.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Est. Completion | 2003-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000452
The ClinicalTrials.gov registry entry for NCT00000452 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavior Therapy is the first listed.
NCT00000452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000452 about?
NCT00000452 is a clinical study titled "Naltrexone Treatment of Alcohol Dependence". The long-range goal of this ongoing research program is to find more effective treatments for alcohol dependence by combining medication with the appropriate psychosocial support. This proposal has three specific aims: (1) to compare the effectiveness of naltrexone (Revia) in three types of treatmen...
What is the current status of trial NCT00000452?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 240 participants. Estimated completion is 2003-01.
What interventions are being tested in trial NCT00000452?
The interventions under investigation include: Cognitive Behavior Therapy (BEHAVIORAL), naltrexone (Revia) (DRUG), Compliance Enhancement Tech. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000452?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.